Cargando…
Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy
BACKGROUND: To evaluate the association between the clinical, dosimetric factors and severe acute radiation pneumonitis (SARP) in patients with locally advanced non-small cell lung cancer (LANSCLC) treated with concurrent chemotherapy and intensity-modulated radiotherapy (IMRT). METHODS: We analyzed...
Autores principales: | Shi, Anhui, Zhu, Guangying, Wu, Hao, Yu, Rong, Li, Fuhai, Xu, Bo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883984/ https://www.ncbi.nlm.nih.gov/pubmed/20462424 http://dx.doi.org/10.1186/1748-717X-5-35 |
Ejemplares similares
-
Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy
por: Cai, Shuhua, et al.
Publicado: (2014) -
Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
por: Ryckman, Jeffrey M., et al.
Publicado: (2020) -
Correction to: Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
por: Ryckman, Jeffrey M., et al.
Publicado: (2021) -
Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy
por: Zhuang, Hongqing, et al.
Publicado: (2014) -
An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy
por: Ma, Li, et al.
Publicado: (2018)